These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30180253)

  • 1. Uric Acid Control in Advanced Chronic Kidney Disease in a Southeastern US Urban Cohort.
    Fülöp T; Koch CA; Norris LT; Rodríguez B; Szarvas T; Lengvárszky Z; Csongrádi É; Dixit MP
    South Med J; 2018 Sep; 111(9):549-555. PubMed ID: 30180253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Allopurinol on Renal Function.
    Krishnamurthy A; Lazaro D; Stefanov DG; Blumenthal D; Gerber D; Patel S
    J Clin Rheumatol; 2017 Jan; 23(1):1-5. PubMed ID: 28002149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.
    Ghane Sharbaf F; Assadi F
    Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease.
    Sakai Y; Otsuka T; Ohno D; Murasawa T; Sato N; Tsuruoka S
    Ren Fail; 2014 Mar; 36(2):225-31. PubMed ID: 24152124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
    Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
    Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Time course of changes in the clinical manifestations of gout in men: data of a 7-year retrospective follow-up].
    Eliseev MS; Barskova VG; Denisov IS
    Ter Arkh; 2015; 87(5):10-15. PubMed ID: 26155614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between glomerular filtration rate, uric acid, and parathyroid hormone in children].
    Diallo D; Dubourg L; Ranchin B; Cochat P; Bacchetta J
    Arch Pediatr; 2013 Jun; 20(6):601-7. PubMed ID: 23642898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.
    Bose B; Badve SV; Hiremath SS; Boudville N; Brown FG; Cass A; de Zoysa JR; Fassett RG; Faull R; Harris DC; Hawley CM; Kanellis J; Palmer SC; Perkovic V; Pascoe EM; Rangan GK; Walker RJ; Walters G; Johnson DW
    Nephrol Dial Transplant; 2014 Feb; 29(2):406-13. PubMed ID: 24042021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Allopurinol Promotes Greater Serum Urate Lowering in Gout Patients with Chronic Kidney Disease Compared with Normal Kidney Function.
    Toprover M; Crittenden DB; Modjinou DV; Oh C; Krasnokutsky S; Fisher MC; Keenan RT; Pillinger MH
    Bull Hosp Jt Dis (2013); 2019 Mar; 77(2):87-91. PubMed ID: 31140959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease.
    Satirapoj B; Wirajit O; Burata A; Supasyndh O; Ruangkanchanasetr P
    J Med Assoc Thai; 2015 Dec; 98(12):1155-61. PubMed ID: 27004299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid and the incidence of CKD and hypertension.
    Kuriyama S; Maruyama Y; Nishio S; Takahashi Y; Kidoguchi S; Kobayashi C; Takahashi D; Sugano N; Hosoya T; Yokoo T
    Clin Exp Nephrol; 2015 Dec; 19(6):1127-34. PubMed ID: 25967597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol Against Progression of Chronic Kidney Disease.
    Golmohammadi S; Almasi A; Manouchehri M; Omrani HR; Zandkarimi MR
    Iran J Kidney Dis; 2017 Jul; 11(4):286-293. PubMed ID: 28794291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.
    Málek F; Ošťádal P; Pařenica J; Jarkovský J; Vítovec J; Widimský P; Linhart A; Fedorco M; Coufal Z; Miklík R; Krűger A; Vondraková D; Špinar J
    J Crit Care; 2012 Dec; 27(6):737.e11-24. PubMed ID: 22699032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
    Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Uric Acid Levels on Kidney Disease Progression.
    Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
    Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between annual changes and visit-to-visit variability of serum uric acid and the kidney outcome in a general population.
    Liu J; Ma Y; Yu G; Wang W
    Ren Fail; 2024 Dec; 46(2):2367702. PubMed ID: 38912897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma uric acid and renal haemodynamics in type 2 diabetes patients.
    Suijk DL; Smits MM; Muskiet MH; Tonneijck L; Kramer MH; Joles JA; van Raalte DH
    Nephrology (Carlton); 2020 Apr; 25(4):290-297. PubMed ID: 31429150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.